Alexis Borisy is Director of Magenta Therapeutics, Inc.. Currently has a direct ownership of 4,100 shares of MGTA, which is worth approximately $0. The most recent transaction as insider was on Aug 26, 2021, when has been sold 4,100 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 4.1K
0% 3M change
0% 12M change
Total Value Held $0

Alexis Borisy Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 26 2021
BUY
Other acquisition or disposition
-
4,100 Added 50.0%
4,100 Common Stock

Also insider at

RLAY
Relay Therapeutics, Inc. Healthcare
BPMC
Blueprint Medicines Corp Healthcare
RVMD
Revolution Medicines, Inc. Healthcare
EQRX
EQRx, Inc. Healthcare
OPK
OPKO HEALTH, INC. Healthcare
TNGX
Tango Therapeutics, Inc. Healthcare
AB

Alexis Borisy

Director
Miami, FL

Track Institutional and Insider Activities on MGTA

Follow Magenta Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MGTA shares.

Notify only if

Insider Trading

Get notified when an Magenta Therapeutics, Inc. insider buys or sells MGTA shares.

Notify only if

News

Receive news related to Magenta Therapeutics, Inc.

Track Activities on MGTA